- Home
- VNCE vs CASI Comparison
VNCE vs CASI Comparison
Compare VNCE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNCE
- CASI
- Stock Information
- Founded
- VNCE 2002
- CASI 1991
- Country
- VNCE United States
- CASI China
- Employees
- VNCE N/A
- CASI N/A
- Industry
- VNCE Clothing/Shoe/Accessory Stores
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- VNCE Consumer Discretionary
- CASI Health Care
- Exchange
- VNCE Nasdaq
- CASI Nasdaq
- Market Cap
- VNCE 20.2M
- CASI 20.5M
- IPO Year
- VNCE 2013
- CASI 1996
- Fundamental
- Price
- VNCE $1.57
- CASI $1.73
- Analyst Decision
- VNCE Strong Buy
- CASI Strong Buy
- Analyst Count
- VNCE 3
- CASI 1
- Target Price
- VNCE $4.17
- CASI $4.00
- AVG Volume (30 Days)
- VNCE 28.5K
- CASI 3.4M
- Earning Date
- VNCE 09-15-2025
- CASI 08-19-2025
- Dividend Yield
- VNCE N/A
- CASI N/A
- EPS Growth
- VNCE N/A
- CASI N/A
- EPS
- VNCE N/A
- CASI N/A
- Revenue
- VNCE $292,214,000.00
- CASI $31,368,000.00
- Revenue This Year
- VNCE $1.93
- CASI N/A
- Revenue Next Year
- VNCE $4.91
- CASI N/A
- P/E Ratio
- VNCE N/A
- CASI N/A
- Revenue Growth
- VNCE 1.46
- CASI 8.39
- 52 Week Low
- VNCE $1.02
- CASI $1.09
- 52 Week High
- VNCE $6.89
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- VNCE 53.89
- CASI 56.44
- Support Level
- VNCE $1.45
- CASI $1.46
- Resistance Level
- VNCE $1.62
- CASI $2.57
- Average True Range (ATR)
- VNCE 0.09
- CASI 0.27
- MACD
- VNCE 0.00
- CASI 0.03
- Stochastic Oscillator
- VNCE 76.19
- CASI 36.84
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.